Cargando…

Correction: Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Open 2017
Materias:	Miscellaneous
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724194/ https://www.ncbi.nlm.nih.gov/pubmed/28801447 http://dx.doi.org/10.1136/bmjopen-2016-015562corr1

Ejemplares similares

Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis
por: van Es, Nick, et al.
Publicado: (2017)

Screening for cancer in unprovoked venous thromboembolism
por: Shivji, Salma, et al.
Publicado: (2019)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
por: Mulder, Frits I., et al.
Publicado: (2020)

Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
por: Moodley, Otto, et al.
Publicado: (2015)

Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach
por: Marcucci, Maura, et al.
Publicado: (2013)

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
por: Khan, Faizan, et al.
Publicado: (2019)

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism
por: Hodeib, Hossam, et al.
Publicado: (2021)

The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms
por: Lee, Su Yeon, et al.
Publicado: (2017)

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2017)

Cancer Screening in Patients with Unprovoked Thromboembolism: How to do it and Who Benefits?
por: Ferreira, Filipa, et al.
Publicado: (2020)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)

Case Report: Unprovoked venous thromboembolism in a young adult male
por: Dhabhar, Jeyhan, et al.
Publicado: (2019)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
por: Ageno, Walter, et al.
Publicado: (2021)

Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study
por: Whitworth, Hilary, et al.
Publicado: (2023)

Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism
por: Han, Donghee, et al.
Publicado: (2016)

Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　― Subanalysis of the J’xactly Study ―
por: Hisatake, Shinji, et al.
Publicado: (2022)

Correction: Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment
Publicado: (2017)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2013)

Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials
por: Li, Dandan, et al.
Publicado: (2022)

Long‐Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events
por: Chang, Wei‐Ting, et al.
Publicado: (2017)

Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?
por: Folsom, Aaron R., et al.
Publicado: (2020)

CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
por: Lee, Ronan J., et al.
Publicado: (2023)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Positron Emission Tomography Combined With Computed Tomography as a Screening Tool for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism: An Observational Study
por: Chauchard, Maria, et al.
Publicado: (2014)

Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism
por: Khan, Faizan, et al.
Publicado: (2023)

Acute myocardial infarction after initially diagnosed with unprovoked venous thromboembolism: A case report
por: Seo, Jeongduk, et al.
Publicado: (2023)

Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
por: Bortoluzzi, Cristiano, et al.
Publicado: (2022)

Performance of (18)F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism
por: Robin, Philippe, et al.
Publicado: (2017)

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
por: Iñurrieta, Amaia, et al.
Publicado: (2018)

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
por: Palareti, Gualtiero, et al.
Publicado: (2022)

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction
por: Hernandez-Lopez, Rubicel, et al.
Publicado: (2017)

Predictive Value for Increased Red Blood Cell Distribution Width in Unprovoked Acute Venous Thromboembolism at the Emergency Department
por: Febra, Cláudia, et al.
Publicado: (2023)

Three Cases of Unprovoked Venous Thromboembolism with Prothrombin p.Arg596Gln Variant and a Literature Review of Antithrombin Resistance
por: Tsuji, Akihiro, et al.
Publicado: (2022)

Epidemiology of venous thromboembolism in Africa: a systematic review and meta-analysis protocol
por: Danwang, Celestin, et al.
Publicado: (2017)

Correction: The association between human herpesvirus infections and stroke: a systematic review protocol
Publicado: (2017)

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
por: Porfidia, Angelo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1fujmrctq2n9tc03t4f9khn7hc